Vikasdeep Gupta1 and Vandana Sharma2*
1Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Bathinda, India
2Department of Ophthalmology, Adesh Institute of Medical Sciences and Research (AIMSR), Bathinda, India
*Corresponding Author: Vandana Sharma, Department of Ophthalmology, Adesh Institute of Medical Sciences and Research (AIMSR), Bathinda, India.
Received: March 14, 2022; Published: March 28, 2022
COVID 19 pandemic has overburdened the healthcare infrastructure in India in the last few months. As the second wave recedes, mucormycosis emerged as a new nemesis which is life and vision threatening to the already immunocompromised post COVID patients. This review article is written with the intent to identify a definitive approach towards early identification of the disease and to formulate guidelines for prompt management.
Keywords: Mucormycosis; COVID-19; Infrastructure
Citation: Vikasdeep Gupta and Vandana Sharma. “Covid Associated Mucormycosis: What do we Know Till Now?".Acta Scientific Otolaryngology 4.4 (2022): 70-74.
Copyright: © 2022 Vikasdeep Gupta and Vandana Sharma. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.